Urinary Nuclear Matrix Protein as a Marker for Transitional Cell Carcinoma of the Urinary Tract
- 1 October 1996
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 156 (4), 1280-1285
- https://doi.org/10.1016/s0022-5347(01)65569-1
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical TreatmentJournal of Urology, 1996
- Detection of bladder tumors by immunostaininc of the lewis x antigen in cells from voided urineUrology, 1995
- Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder CancerJournal of Urology, 1995
- Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cellsCancer, 1993
- NuMA is required for the proper completion of mitosis.The Journal of cell biology, 1993
- NuMA: an unusually long coiled-coil related protein in the mammalian nucleus.The Journal of cell biology, 1992
- Biology and Management of Bladder CancerNew England Journal of Medicine, 1990
- Mapping replicational sites in the eucaryotic cell nucleus.The Journal of cell biology, 1989
- A fixed site of DNA replication in eucaryotic cellsCell, 1980
- Identification of a nuclear protein matrixBiochemical and Biophysical Research Communications, 1974